A strong increase in the number of CD19+CD20+CD27+IgD+ NSw MBCs was observed in the blood of patients with MASLD compared with controls (Fig. S8E), which fully correlated with murine data (Fig. 8F). This evidence concerns the gene CD19 and metabolic dysfunction-associated steatotic liver disease.